nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—ADRB1—obesity	0.262	0.543	CbGaD
Levobunolol—ADRB2—obesity	0.22	0.457	CbGaD
Levobunolol—ADRB2—Phenylpropanolamine—obesity	0.182	0.504	CbGbCtD
Levobunolol—ADRB1—Phenylpropanolamine—obesity	0.179	0.496	CbGbCtD
Levobunolol—Block heart—Cimetidine—obesity	0.00278	0.0308	CcSEcCtD
Levobunolol—Diabetic—Orlistat—obesity	0.00261	0.0289	CcSEcCtD
Levobunolol—Cerebral ischaemia—Sibutramine—obesity	0.00174	0.0193	CcSEcCtD
Levobunolol—Atrioventricular block—Cimetidine—obesity	0.00162	0.018	CcSEcCtD
Levobunolol—Erectile dysfunction—Methamphetamine—obesity	0.00153	0.017	CcSEcCtD
Levobunolol—Cerebrovascular accident—Phentermine—obesity	0.00141	0.0156	CcSEcCtD
Levobunolol—Diabetic—Topiramate—obesity	0.0014	0.0155	CcSEcCtD
Levobunolol—Ataxia—Phenylpropanolamine—obesity	0.00136	0.015	CcSEcCtD
Levobunolol—Cardiac arrest—Phentermine—obesity	0.00131	0.0146	CcSEcCtD
Levobunolol—Cerebrovascular accident—Diethylpropion—obesity	0.00123	0.0136	CcSEcCtD
Levobunolol—Erectile dysfunction—Phentermine—obesity	0.0011	0.0122	CcSEcCtD
Levobunolol—Palpitations—Methamphetamine—obesity	0.00102	0.0113	CcSEcCtD
Levobunolol—Palpitations—Benzphetamine—obesity	0.000987	0.0109	CcSEcCtD
Levobunolol—Erectile dysfunction—Diethylpropion—obesity	0.000957	0.0106	CcSEcCtD
Levobunolol—Erectile dysfunction—Cimetidine—obesity	0.00091	0.0101	CcSEcCtD
Levobunolol—Palpitations—Phendimetrazine—obesity	0.000899	0.00996	CcSEcCtD
Levobunolol—Arrhythmia—Phenylpropanolamine—obesity	0.000892	0.00988	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Cimetidine—obesity	0.000874	0.00968	CcSEcCtD
Levobunolol—Bradycardia—Cimetidine—obesity	0.000805	0.00892	CcSEcCtD
Levobunolol—Urticaria—Methamphetamine—obesity	0.000751	0.00832	CcSEcCtD
Levobunolol—Erythema multiforme—Cimetidine—obesity	0.000748	0.00829	CcSEcCtD
Levobunolol—Arrhythmia—Diethylpropion—obesity	0.000743	0.00823	CcSEcCtD
Levobunolol—Palpitations—Phentermine—obesity	0.000735	0.00814	CcSEcCtD
Levobunolol—Alopecia—Diethylpropion—obesity	0.000735	0.00814	CcSEcCtD
Levobunolol—Diabetes mellitus—Orlistat—obesity	0.000726	0.00804	CcSEcCtD
Levobunolol—Urticaria—Benzphetamine—obesity	0.000724	0.00802	CcSEcCtD
Levobunolol—Confusional state—Phenylpropanolamine—obesity	0.000716	0.00793	CcSEcCtD
Levobunolol—Chest pain—Phentermine—obesity	0.000708	0.00785	CcSEcCtD
Levobunolol—Diabetes mellitus—Sibutramine—obesity	0.000703	0.00778	CcSEcCtD
Levobunolol—Alopecia—Cimetidine—obesity	0.000699	0.00774	CcSEcCtD
Levobunolol—Hypersensitivity—Methamphetamine—obesity	0.000696	0.00771	CcSEcCtD
Levobunolol—Cardiac failure congestive—Sibutramine—obesity	0.000674	0.00746	CcSEcCtD
Levobunolol—Hypersensitivity—Benzphetamine—obesity	0.000672	0.00744	CcSEcCtD
Levobunolol—Nasal congestion—Sibutramine—obesity	0.000671	0.00743	CcSEcCtD
Levobunolol—Hypotension—Phenylpropanolamine—obesity	0.000663	0.00734	CcSEcCtD
Levobunolol—Hypoglycaemia—Orlistat—obesity	0.000647	0.00717	CcSEcCtD
Levobunolol—Diarrhoea—Methamphetamine—obesity	0.000647	0.00716	CcSEcCtD
Levobunolol—Timolol—ADRB3—obesity	0.000642	0.114	CrCbGaD
Levobunolol—Palpitations—Diethylpropion—obesity	0.00064	0.00709	CcSEcCtD
Levobunolol—Dyspnoea—Phenylpropanolamine—obesity	0.000633	0.00701	CcSEcCtD
Levobunolol—Hypoglycaemia—Sibutramine—obesity	0.000626	0.00694	CcSEcCtD
Levobunolol—Dizziness—Methamphetamine—obesity	0.000625	0.00692	CcSEcCtD
Levobunolol—Diarrhoea—Benzphetamine—obesity	0.000624	0.00691	CcSEcCtD
Levobunolol—Cerebrovascular accident—Sibutramine—obesity	0.000624	0.00691	CcSEcCtD
Levobunolol—Chest pain—Diethylpropion—obesity	0.000616	0.00683	CcSEcCtD
Levobunolol—Dizziness—Benzphetamine—obesity	0.000603	0.00668	CcSEcCtD
Levobunolol—Headache—Methamphetamine—obesity	0.000592	0.00656	CcSEcCtD
Levobunolol—Nasal congestion—Bupropion—obesity	0.000585	0.00648	CcSEcCtD
Levobunolol—Feeling abnormal—Phenylpropanolamine—obesity	0.000585	0.00648	CcSEcCtD
Levobunolol—Cardiac arrest—Sibutramine—obesity	0.000581	0.00644	CcSEcCtD
Levobunolol—Ataxia—Sibutramine—obesity	0.000575	0.00636	CcSEcCtD
Levobunolol—Headache—Benzphetamine—obesity	0.000571	0.00632	CcSEcCtD
Levobunolol—Diarrhoea—Phendimetrazine—obesity	0.000568	0.0063	CcSEcCtD
Levobunolol—Confusional state—Cimetidine—obesity	0.000567	0.00628	CcSEcCtD
Levobunolol—Visual disturbance—Bupropion—obesity	0.000562	0.00623	CcSEcCtD
Levobunolol—Dizziness—Phendimetrazine—obesity	0.000549	0.00608	CcSEcCtD
Levobunolol—Hypoglycaemia—Bupropion—obesity	0.000546	0.00605	CcSEcCtD
Levobunolol—Cerebrovascular accident—Bupropion—obesity	0.000544	0.00602	CcSEcCtD
Levobunolol—Lethargy—Bupropion—obesity	0.000544	0.00602	CcSEcCtD
Levobunolol—Nausea—Benzphetamine—obesity	0.000541	0.006	CcSEcCtD
Levobunolol—Urticaria—Phentermine—obesity	0.000539	0.00598	CcSEcCtD
Levobunolol—Bronchospasm—Orlistat—obesity	0.000537	0.00595	CcSEcCtD
Levobunolol—Diplopia—Bupropion—obesity	0.000533	0.0059	CcSEcCtD
Levobunolol—Dyspnoea—Diethylpropion—obesity	0.000527	0.00583	CcSEcCtD
Levobunolol—Hypersensitivity—Phenylpropanolamine—obesity	0.000523	0.00579	CcSEcCtD
Levobunolol—Headache—Phendimetrazine—obesity	0.00052	0.00576	CcSEcCtD
Levobunolol—Nadolol—ADRB3—obesity	0.00051	0.0907	CrCbGaD
Levobunolol—Ataxia—Bupropion—obesity	0.000501	0.00555	CcSEcCtD
Levobunolol—Nausea—Phendimetrazine—obesity	0.000493	0.00547	CcSEcCtD
Levobunolol—Asthenia—Phentermine—obesity	0.000487	0.0054	CcSEcCtD
Levobunolol—Feeling abnormal—Diethylpropion—obesity	0.000487	0.00539	CcSEcCtD
Levobunolol—Erectile dysfunction—Sibutramine—obesity	0.000486	0.00539	CcSEcCtD
Levobunolol—Bupranolol—ADRB3—obesity	0.000486	0.0866	CrCbGaD
Levobunolol—Depression—Orlistat—obesity	0.000485	0.00537	CcSEcCtD
Levobunolol—Atrioventricular block—Topiramate—obesity	0.000482	0.00534	CcSEcCtD
Levobunolol—Depression—Sibutramine—obesity	0.00047	0.0052	CcSEcCtD
Levobunolol—Urticaria—Diethylpropion—obesity	0.000469	0.0052	CcSEcCtD
Levobunolol—Dizziness—Phenylpropanolamine—obesity	0.000469	0.0052	CcSEcCtD
Levobunolol—Diarrhoea—Phentermine—obesity	0.000465	0.00515	CcSEcCtD
Levobunolol—Feeling abnormal—Cimetidine—obesity	0.000463	0.00513	CcSEcCtD
Levobunolol—Conjunctivitis—Sibutramine—obesity	0.000458	0.00507	CcSEcCtD
Levobunolol—Bronchospasm—Bupropion—obesity	0.000453	0.00502	CcSEcCtD
Levobunolol—Dizziness—Phentermine—obesity	0.000449	0.00497	CcSEcCtD
Levobunolol—Bradycardia—Sibutramine—obesity	0.00043	0.00477	CcSEcCtD
Levobunolol—Headache—Phentermine—obesity	0.000425	0.00471	CcSEcCtD
Levobunolol—Erectile dysfunction—Bupropion—obesity	0.000424	0.0047	CcSEcCtD
Levobunolol—Nausea—Phenylpropanolamine—obesity	0.000422	0.00467	CcSEcCtD
Levobunolol—Hypersensitivity—Cimetidine—obesity	0.000414	0.00459	CcSEcCtD
Levobunolol—Visual impairment—Sibutramine—obesity	0.000407	0.00451	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Bupropion—obesity	0.000407	0.00451	CcSEcCtD
Levobunolol—Diarrhoea—Diethylpropion—obesity	0.000404	0.00448	CcSEcCtD
Levobunolol—Nausea—Phentermine—obesity	0.000403	0.00447	CcSEcCtD
Levobunolol—Asthenia—Cimetidine—obesity	0.000403	0.00447	CcSEcCtD
Levobunolol—Conjunctivitis—Bupropion—obesity	0.000399	0.00442	CcSEcCtD
Levobunolol—Dizziness—Diethylpropion—obesity	0.000391	0.00433	CcSEcCtD
Levobunolol—Diabetes mellitus—Topiramate—obesity	0.00039	0.00432	CcSEcCtD
Levobunolol—Alopecia—Orlistat—obesity	0.000386	0.00428	CcSEcCtD
Levobunolol—Diarrhoea—Cimetidine—obesity	0.000385	0.00426	CcSEcCtD
Levobunolol—Arrhythmia—Sibutramine—obesity	0.000378	0.00418	CcSEcCtD
Levobunolol—Alopecia—Sibutramine—obesity	0.000374	0.00414	CcSEcCtD
Levobunolol—Nasal congestion—Topiramate—obesity	0.000373	0.00413	CcSEcCtD
Levobunolol—Dizziness—Cimetidine—obesity	0.000372	0.00412	CcSEcCtD
Levobunolol—Headache—Diethylpropion—obesity	0.00037	0.0041	CcSEcCtD
Levobunolol—Visual disturbance—Topiramate—obesity	0.000358	0.00397	CcSEcCtD
Levobunolol—Visual impairment—Bupropion—obesity	0.000355	0.00393	CcSEcCtD
Levobunolol—Headache—Cimetidine—obesity	0.000352	0.0039	CcSEcCtD
Levobunolol—Nausea—Diethylpropion—obesity	0.000351	0.00389	CcSEcCtD
Levobunolol—Erythema multiforme—Bupropion—obesity	0.000348	0.00386	CcSEcCtD
Levobunolol—Hypoglycaemia—Topiramate—obesity	0.000348	0.00385	CcSEcCtD
Levobunolol—Lethargy—Topiramate—obesity	0.000346	0.00384	CcSEcCtD
Levobunolol—Diplopia—Topiramate—obesity	0.000339	0.00376	CcSEcCtD
Levobunolol—Palpitations—Orlistat—obesity	0.000336	0.00372	CcSEcCtD
Levobunolol—Nausea—Cimetidine—obesity	0.000334	0.0037	CcSEcCtD
Levobunolol—Syncope—Sibutramine—obesity	0.00033	0.00366	CcSEcCtD
Levobunolol—Arrhythmia—Bupropion—obesity	0.000329	0.00365	CcSEcCtD
Levobunolol—Alopecia—Bupropion—obesity	0.000326	0.00361	CcSEcCtD
Levobunolol—Palpitations—Sibutramine—obesity	0.000325	0.0036	CcSEcCtD
Levobunolol—Chest pain—Orlistat—obesity	0.000324	0.00359	CcSEcCtD
Levobunolol—Loss of consciousness—Sibutramine—obesity	0.000323	0.00358	CcSEcCtD
Levobunolol—Pindolol—ADRB3—obesity	0.000321	0.0571	CrCbGaD
Levobunolol—Ataxia—Topiramate—obesity	0.000319	0.00353	CcSEcCtD
Levobunolol—Chest pain—Sibutramine—obesity	0.000313	0.00347	CcSEcCtD
Levobunolol—Confusional state—Sibutramine—obesity	0.000303	0.00335	CcSEcCtD
Levobunolol—Shock—Sibutramine—obesity	0.000295	0.00327	CcSEcCtD
Levobunolol—Timolol—ADRB1—obesity	0.00029	0.0516	CrCbGaD
Levobunolol—Syncope—Bupropion—obesity	0.000288	0.00319	CcSEcCtD
Levobunolol—Palpitations—Bupropion—obesity	0.000284	0.00314	CcSEcCtD
Levobunolol—Loss of consciousness—Bupropion—obesity	0.000282	0.00312	CcSEcCtD
Levobunolol—Hypotension—Sibutramine—obesity	0.000281	0.00311	CcSEcCtD
Levobunolol—Paraesthesia—Orlistat—obesity	0.000279	0.00309	CcSEcCtD
Levobunolol—Chest pain—Bupropion—obesity	0.000273	0.00303	CcSEcCtD
Levobunolol—Erectile dysfunction—Topiramate—obesity	0.00027	0.00299	CcSEcCtD
Levobunolol—Paraesthesia—Sibutramine—obesity	0.00027	0.00299	CcSEcCtD
Levobunolol—Dyspnoea—Sibutramine—obesity	0.000268	0.00297	CcSEcCtD
Levobunolol—Pain—Orlistat—obesity	0.000265	0.00294	CcSEcCtD
Levobunolol—Confusional state—Bupropion—obesity	0.000264	0.00292	CcSEcCtD
Levobunolol—Depression—Topiramate—obesity	0.000261	0.00289	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Topiramate—obesity	0.000259	0.00287	CcSEcCtD
Levobunolol—Carteolol—ADRB1—obesity	0.000259	0.046	CrCbGaD
Levobunolol—Shock—Bupropion—obesity	0.000258	0.00285	CcSEcCtD
Levobunolol—Pain—Sibutramine—obesity	0.000257	0.00284	CcSEcCtD
Levobunolol—Feeling abnormal—Orlistat—obesity	0.000256	0.00283	CcSEcCtD
Levobunolol—Conjunctivitis—Topiramate—obesity	0.000254	0.00282	CcSEcCtD
Levobunolol—Feeling abnormal—Sibutramine—obesity	0.000247	0.00274	CcSEcCtD
Levobunolol—Urticaria—Orlistat—obesity	0.000247	0.00273	CcSEcCtD
Levobunolol—Hypotension—Bupropion—obesity	0.000245	0.00271	CcSEcCtD
Levobunolol—Timolol—ADRB2—obesity	0.000244	0.0434	CrCbGaD
Levobunolol—Bradycardia—Topiramate—obesity	0.000239	0.00265	CcSEcCtD
Levobunolol—Urticaria—Sibutramine—obesity	0.000239	0.00264	CcSEcCtD
Levobunolol—Paraesthesia—Bupropion—obesity	0.000235	0.0026	CcSEcCtD
Levobunolol—Dyspnoea—Bupropion—obesity	0.000233	0.00259	CcSEcCtD
Levobunolol—Nadolol—ADRB1—obesity	0.00023	0.041	CrCbGaD
Levobunolol—Hypersensitivity—Orlistat—obesity	0.000229	0.00253	CcSEcCtD
Levobunolol—Penbutolol—HTR1B—obesity	0.000227	0.0405	CrCbGaD
Levobunolol—Visual impairment—Topiramate—obesity	0.000226	0.00251	CcSEcCtD
Levobunolol—Pain—Bupropion—obesity	0.000224	0.00248	CcSEcCtD
Levobunolol—Asthenia—Orlistat—obesity	0.000223	0.00247	CcSEcCtD
Levobunolol—Erythema multiforme—Topiramate—obesity	0.000222	0.00246	CcSEcCtD
Levobunolol—Hypersensitivity—Sibutramine—obesity	0.000221	0.00245	CcSEcCtD
Levobunolol—Bupranolol—ADRB1—obesity	0.00022	0.0391	CrCbGaD
Levobunolol—Pruritus—Orlistat—obesity	0.00022	0.00243	CcSEcCtD
Levobunolol—Carteolol—ADRB2—obesity	0.000217	0.0387	CrCbGaD
Levobunolol—Feeling abnormal—Bupropion—obesity	0.000216	0.00239	CcSEcCtD
Levobunolol—Asthenia—Sibutramine—obesity	0.000215	0.00239	CcSEcCtD
Levobunolol—Pruritus—Sibutramine—obesity	0.000212	0.00235	CcSEcCtD
Levobunolol—Diarrhoea—Orlistat—obesity	0.000212	0.00235	CcSEcCtD
Levobunolol—Urticaria—Bupropion—obesity	0.000208	0.0023	CcSEcCtD
Levobunolol—Alopecia—Topiramate—obesity	0.000207	0.0023	CcSEcCtD
Levobunolol—Salbutamol—ADRB1—obesity	0.000207	0.0368	CrCbGaD
Levobunolol—Diarrhoea—Sibutramine—obesity	0.000205	0.00228	CcSEcCtD
Levobunolol—Dizziness—Orlistat—obesity	0.000205	0.00227	CcSEcCtD
Levobunolol—Penbutolol—ADRB1—obesity	0.000201	0.0358	CrCbGaD
Levobunolol—Dizziness—Sibutramine—obesity	0.000199	0.0022	CcSEcCtD
Levobunolol—Headache—Orlistat—obesity	0.000194	0.00215	CcSEcCtD
Levobunolol—Nadolol—ADRB2—obesity	0.000194	0.0345	CrCbGaD
Levobunolol—Hypersensitivity—Bupropion—obesity	0.000193	0.00214	CcSEcCtD
Levobunolol—Headache—Sibutramine—obesity	0.000188	0.00208	CcSEcCtD
Levobunolol—Asthenia—Bupropion—obesity	0.000188	0.00208	CcSEcCtD
Levobunolol—Pruritus—Bupropion—obesity	0.000185	0.00205	CcSEcCtD
Levobunolol—Bupranolol—ADRB2—obesity	0.000185	0.0329	CrCbGaD
Levobunolol—Nausea—Orlistat—obesity	0.000184	0.00204	CcSEcCtD
Levobunolol—Syncope—Topiramate—obesity	0.000183	0.00203	CcSEcCtD
Levobunolol—Palpitations—Topiramate—obesity	0.000181	0.002	CcSEcCtD
Levobunolol—Loss of consciousness—Topiramate—obesity	0.00018	0.00199	CcSEcCtD
Levobunolol—Diarrhoea—Bupropion—obesity	0.000179	0.00198	CcSEcCtD
Levobunolol—Nausea—Sibutramine—obesity	0.000178	0.00198	CcSEcCtD
Levobunolol—Propranolol—ADRB3—obesity	0.000175	0.0311	CrCbGaD
Levobunolol—Chest pain—Topiramate—obesity	0.000174	0.00193	CcSEcCtD
Levobunolol—Salbutamol—ADRB2—obesity	0.000174	0.0309	CrCbGaD
Levobunolol—Dizziness—Bupropion—obesity	0.000173	0.00192	CcSEcCtD
Levobunolol—Penbutolol—ADRB2—obesity	0.000169	0.0301	CrCbGaD
Levobunolol—Confusional state—Topiramate—obesity	0.000168	0.00186	CcSEcCtD
Levobunolol—Shock—Topiramate—obesity	0.000164	0.00182	CcSEcCtD
Levobunolol—Headache—Bupropion—obesity	0.000164	0.00182	CcSEcCtD
Levobunolol—Pindolol—HTR1B—obesity	0.000164	0.0292	CrCbGaD
Levobunolol—Hypotension—Topiramate—obesity	0.000156	0.00173	CcSEcCtD
Levobunolol—Nausea—Bupropion—obesity	0.000156	0.00172	CcSEcCtD
Levobunolol—Paraesthesia—Topiramate—obesity	0.00015	0.00166	CcSEcCtD
Levobunolol—Dyspnoea—Topiramate—obesity	0.000149	0.00165	CcSEcCtD
Levobunolol—Pindolol—ADRB1—obesity	0.000145	0.0258	CrCbGaD
Levobunolol—Pain—Topiramate—obesity	0.000143	0.00158	CcSEcCtD
Levobunolol—Feeling abnormal—Topiramate—obesity	0.000137	0.00152	CcSEcCtD
Levobunolol—Urticaria—Topiramate—obesity	0.000133	0.00147	CcSEcCtD
Levobunolol—Hypersensitivity—Topiramate—obesity	0.000123	0.00136	CcSEcCtD
Levobunolol—Pindolol—ADRB2—obesity	0.000122	0.0217	CrCbGaD
Levobunolol—Asthenia—Topiramate—obesity	0.00012	0.00133	CcSEcCtD
Levobunolol—Pruritus—Topiramate—obesity	0.000118	0.00131	CcSEcCtD
Levobunolol—Diarrhoea—Topiramate—obesity	0.000114	0.00126	CcSEcCtD
Levobunolol—Dizziness—Topiramate—obesity	0.00011	0.00122	CcSEcCtD
Levobunolol—Headache—Topiramate—obesity	0.000105	0.00116	CcSEcCtD
Levobunolol—Nausea—Topiramate—obesity	9.91e-05	0.0011	CcSEcCtD
Levobunolol—Propranolol—HTR1B—obesity	8.94e-05	0.0159	CrCbGaD
Levobunolol—Propranolol—ADRB1—obesity	7.91e-05	0.0141	CrCbGaD
Levobunolol—Propranolol—ADRB2—obesity	6.65e-05	0.0118	CrCbGaD
Levobunolol—ADRB2—Signaling by GPCR—DRD4—obesity	2.35e-05	0.000384	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CCL2—obesity	2.33e-05	0.000381	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CNR1—obesity	2.29e-05	0.000374	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CNR1—obesity	2.24e-05	0.000366	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—DRD2—obesity	2.23e-05	0.000365	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GCG—obesity	2.21e-05	0.000362	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRB2—obesity	2.2e-05	0.00036	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRB3—obesity	2.19e-05	0.000358	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—DRD2—obesity	2.18e-05	0.000357	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GCG—obesity	2.16e-05	0.000354	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRB3—obesity	2.14e-05	0.00035	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GAL—obesity	2.14e-05	0.00035	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—C5AR1—obesity	2.11e-05	0.000346	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GNB3—obesity	2.1e-05	0.000343	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GAL—obesity	2.09e-05	0.000342	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—C5AR1—obesity	2.07e-05	0.000338	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GNB3—obesity	2.05e-05	0.000336	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GNAS—obesity	2.04e-05	0.000334	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRB2—obesity	2e-05	0.000327	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GNAS—obesity	2e-05	0.000327	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CCL5—obesity	1.95e-05	0.00032	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKG1—obesity	1.93e-05	0.000316	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCK—obesity	1.93e-05	0.000316	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CCL5—obesity	1.91e-05	0.000313	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GNB3—obesity	1.91e-05	0.000312	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCK—obesity	1.89e-05	0.000309	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKG1—obesity	1.89e-05	0.000309	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RBP4—obesity	1.88e-05	0.000308	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GLP1R—obesity	1.88e-05	0.000308	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GNB3—obesity	1.86e-05	0.000305	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GNAS—obesity	1.86e-05	0.000303	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCKAR—obesity	1.85e-05	0.000303	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HRH3—obesity	1.85e-05	0.000303	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RBP4—obesity	1.84e-05	0.000301	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GLP1R—obesity	1.84e-05	0.000301	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GNAS—obesity	1.81e-05	0.000297	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCKAR—obesity	1.81e-05	0.000297	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HRH3—obesity	1.81e-05	0.000297	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKAR2B—obesity	1.78e-05	0.000292	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCL5—obesity	1.77e-05	0.00029	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PRKCD—obesity	1.76e-05	0.000288	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKAR2B—obesity	1.75e-05	0.000285	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCL5—obesity	1.74e-05	0.000284	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NCF2—obesity	1.72e-05	0.000282	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2A—obesity	1.72e-05	0.000282	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PRKCD—obesity	1.72e-05	0.000282	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—C3—obesity	1.72e-05	0.000281	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NCF2—obesity	1.69e-05	0.000276	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2A—obesity	1.68e-05	0.000276	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—C3—obesity	1.68e-05	0.000275	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NPY—obesity	1.68e-05	0.000275	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOC3—obesity	1.67e-05	0.000273	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IAPP—obesity	1.67e-05	0.000273	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NPY—obesity	1.64e-05	0.000269	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AGT—obesity	1.63e-05	0.000267	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOC3—obesity	1.63e-05	0.000267	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IAPP—obesity	1.63e-05	0.000267	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CRH—obesity	1.62e-05	0.000265	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR1B—obesity	1.62e-05	0.000265	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SDC1—obesity	1.6e-05	0.000262	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AGT—obesity	1.6e-05	0.000261	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PRKCD—obesity	1.6e-05	0.000261	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR1B—obesity	1.58e-05	0.000259	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CRH—obesity	1.58e-05	0.000259	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKR1C3—obesity	1.58e-05	0.000258	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SDC1—obesity	1.57e-05	0.000256	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2A—obesity	1.56e-05	0.000256	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PRKCD—obesity	1.56e-05	0.000256	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—C3—obesity	1.56e-05	0.000255	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKR1C3—obesity	1.54e-05	0.000252	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NPS—obesity	1.54e-05	0.000251	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2A—obesity	1.53e-05	0.00025	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—C3—obesity	1.53e-05	0.00025	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—F2—obesity	1.51e-05	0.000247	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PRKCB—obesity	1.51e-05	0.000247	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2C—obesity	1.51e-05	0.000246	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DRD1—obesity	1.51e-05	0.000246	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NPS—obesity	1.5e-05	0.000246	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AGT—obesity	1.48e-05	0.000243	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—F2—obesity	1.48e-05	0.000242	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PRKCB—obesity	1.48e-05	0.000242	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2C—obesity	1.47e-05	0.000241	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DRD1—obesity	1.47e-05	0.000241	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NTRK2—obesity	1.47e-05	0.00024	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AGT—obesity	1.45e-05	0.000237	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3CG—obesity	1.45e-05	0.000236	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NTRK2—obesity	1.43e-05	0.000234	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PARP1—obesity	1.43e-05	0.000234	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GHRL—obesity	1.43e-05	0.000234	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRB1—obesity	1.43e-05	0.000233	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DRD4—obesity	1.42e-05	0.000232	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3CG—obesity	1.41e-05	0.000231	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PARP1—obesity	1.4e-05	0.000228	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GHRL—obesity	1.4e-05	0.000228	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DRD4—obesity	1.39e-05	0.000227	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—POMC—obesity	1.38e-05	0.000225	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PRKCB—obesity	1.37e-05	0.000224	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—F2—obesity	1.37e-05	0.000224	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CNR1—obesity	1.35e-05	0.000221	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—POMC—obesity	1.35e-05	0.00022	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—F2—obesity	1.34e-05	0.000219	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PRKCB—obesity	1.34e-05	0.000219	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TCF7L2—obesity	1.33e-05	0.000217	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CNR1—obesity	1.32e-05	0.000216	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT2—obesity	1.32e-05	0.000216	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DRD2—obesity	1.32e-05	0.000216	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3CG—obesity	1.31e-05	0.000215	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GCG—obesity	1.31e-05	0.000214	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PTPN1—obesity	1.31e-05	0.000214	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TCF7L2—obesity	1.3e-05	0.000213	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT2—obesity	1.29e-05	0.000212	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DRD2—obesity	1.29e-05	0.000211	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3CG—obesity	1.28e-05	0.00021	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PTPN1—obesity	1.28e-05	0.000209	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GCG—obesity	1.28e-05	0.000209	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3CD—obesity	1.27e-05	0.000208	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—POMC—obesity	1.25e-05	0.000204	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRL—obesity	1.25e-05	0.000204	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3CD—obesity	1.24e-05	0.000203	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—STK11—obesity	1.23e-05	0.000201	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCL2—obesity	1.22e-05	0.0002	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—POMC—obesity	1.22e-05	0.0002	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRL—obesity	1.22e-05	0.000199	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLG—obesity	1.21e-05	0.000199	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—RHOA—obesity	1.21e-05	0.000198	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—STK11—obesity	1.2e-05	0.000196	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT2—obesity	1.2e-05	0.000196	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	1.2e-05	0.000196	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCL2—obesity	1.2e-05	0.000196	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLG—obesity	1.19e-05	0.000194	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—RHOA—obesity	1.19e-05	0.000194	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FOXO3—obesity	1.19e-05	0.000194	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRB2—obesity	1.18e-05	0.000193	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT2—obesity	1.17e-05	0.000192	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	1.17e-05	0.000192	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SOCS1—obesity	1.16e-05	0.00019	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FOXO3—obesity	1.16e-05	0.00019	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3CD—obesity	1.15e-05	0.000189	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SOCS3—obesity	1.15e-05	0.000188	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SOCS1—obesity	1.14e-05	0.000186	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3CD—obesity	1.13e-05	0.000185	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GNB3—obesity	1.13e-05	0.000184	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SOCS3—obesity	1.12e-05	0.000184	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—TYK2—obesity	1.11e-05	0.000182	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	1.11e-05	0.000181	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF2—obesity	1.11e-05	0.000181	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GNB3—obesity	1.1e-05	0.00018	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—RHOA—obesity	1.1e-05	0.00018	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GNAS—obesity	1.1e-05	0.000179	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3R1—obesity	1.09e-05	0.000178	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—TYK2—obesity	1.09e-05	0.000178	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	1.08e-05	0.000177	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF2—obesity	1.08e-05	0.000177	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—RHOA—obesity	1.08e-05	0.000176	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOB—obesity	1.07e-05	0.000176	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GNAS—obesity	1.07e-05	0.000175	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3R1—obesity	1.07e-05	0.000174	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOB—obesity	1.05e-05	0.000172	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL5—obesity	1.05e-05	0.000171	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL5—obesity	1.03e-05	0.000168	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LPL—obesity	1.02e-05	0.000168	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FOXO1—obesity	1.02e-05	0.000166	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RPS6KB1—obesity	1.02e-05	0.000166	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3CB—obesity	1.01e-05	0.000164	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LPL—obesity	1e-05	0.000164	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FOXO1—obesity	9.95e-06	0.000163	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RPS6KB1—obesity	9.94e-06	0.000163	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3CB—obesity	9.84e-06	0.000161	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKCD—obesity	9.44e-06	0.000154	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2A—obesity	9.24e-06	0.000151	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKCD—obesity	9.24e-06	0.000151	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—C3—obesity	9.23e-06	0.000151	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2A—obesity	9.04e-06	0.000148	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—C3—obesity	9.03e-06	0.000148	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IRS2—obesity	8.78e-06	0.000144	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGT—obesity	8.77e-06	0.000143	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LEP—obesity	8.59e-06	0.000141	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOE—obesity	8.59e-06	0.000141	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IRS2—obesity	8.59e-06	0.00014	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGT—obesity	8.58e-06	0.00014	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CAV1—obesity	8.51e-06	0.000139	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOA1—obesity	8.49e-06	0.000139	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOE—obesity	8.4e-06	0.000137	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LEP—obesity	8.4e-06	0.000137	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CAV1—obesity	8.33e-06	0.000136	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOA1—obesity	8.31e-06	0.000136	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ESR1—obesity	8.2e-06	0.000134	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKCB—obesity	8.1e-06	0.000133	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—F2—obesity	8.1e-06	0.000133	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ESR1—obesity	8.02e-06	0.000131	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—BAD—obesity	8e-06	0.000131	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—F2—obesity	7.92e-06	0.00013	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKCB—obesity	7.92e-06	0.00013	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—BAD—obesity	7.83e-06	0.000128	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3CG—obesity	7.75e-06	0.000127	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IRS1—obesity	7.66e-06	0.000125	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3CG—obesity	7.58e-06	0.000124	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IRS1—obesity	7.5e-06	0.000123	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—POMC—obesity	7.38e-06	0.000121	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—INS—obesity	7.34e-06	0.00012	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL2—obesity	7.22e-06	0.000118	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—POMC—obesity	7.22e-06	0.000118	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—INS—obesity	7.18e-06	0.000117	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF1—obesity	7.1e-06	0.000116	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT2—obesity	7.09e-06	0.000116	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL2—obesity	7.06e-06	0.000116	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF1—obesity	6.94e-06	0.000114	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT2—obesity	6.94e-06	0.000113	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3CD—obesity	6.82e-06	0.000111	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	6.75e-06	0.00011	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SERPINE1—obesity	6.74e-06	0.00011	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3CD—obesity	6.67e-06	0.000109	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	6.6e-06	0.000108	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SERPINE1—obesity	6.59e-06	0.000108	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TYK2—obesity	6.56e-06	0.000107	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RHOA—obesity	6.5e-06	0.000106	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3R1—obesity	6.44e-06	0.000105	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOS3—obesity	6.44e-06	0.000105	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TYK2—obesity	6.41e-06	0.000105	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RHOA—obesity	6.36e-06	0.000104	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3R1—obesity	6.3e-06	0.000103	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOS3—obesity	6.3e-06	0.000103	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3CA—obesity	6.13e-06	0.0001	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3CA—obesity	6e-06	9.81e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MTOR—obesity	5.94e-06	9.72e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3CB—obesity	5.94e-06	9.72e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MTOR—obesity	5.81e-06	9.5e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3CB—obesity	5.81e-06	9.5e-05	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT1—obesity	5.51e-06	9.02e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6—obesity	5.43e-06	8.88e-05	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT1—obesity	5.39e-06	8.82e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6—obesity	5.31e-06	8.69e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MMP9—obesity	5.16e-06	8.45e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MMP9—obesity	5.05e-06	8.26e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAPK8—obesity	5.02e-06	8.21e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT1—obesity	5.01e-06	8.19e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAPK8—obesity	4.91e-06	8.03e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT1—obesity	4.9e-06	8.01e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—STAT3—obesity	4.59e-06	7.51e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—STAT3—obesity	4.49e-06	7.35e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MYC—obesity	4.27e-06	6.98e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TGFB1—obesity	4.26e-06	6.96e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MYC—obesity	4.17e-06	6.83e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TGFB1—obesity	4.16e-06	6.81e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3CA—obesity	3.62e-06	5.92e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3CA—obesity	3.54e-06	5.79e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6—obesity	3.21e-06	5.24e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6—obesity	3.14e-06	5.13e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT1—obesity	2.96e-06	4.84e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT1—obesity	2.89e-06	4.73e-05	CbGpPWpGaD
